Načítá se...
Monoclonal antibodies in acute lymphoblastic leukemia
With modern intensive combination polychemotherapy, the complete response (CR) rate in adults with acute lymphoblastic leukemia (ALL) is 80% to 90%, and the cure rate is 40% to 50%. Hence, there is a need to develop effective salvage therapies and combine novel agents with standard effective chemoth...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548495/ https://ncbi.nlm.nih.gov/pubmed/25999456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-08-596403 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|